Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Artemis Therapeutics Inc. stock logo
ATMS
Artemis Therapeutics
$0.04
$0.06
$0.11
$5.00
$4.48M-1.922,942 shsN/A
Cosmos Health Inc. stock logo
COSM
Cosmos Health
$0.68
$0.69
$0.47
$4.00
$11.51M5.84137,718 shs63,901 shs
Captor Capital Corp. stock logo
CPTRF
Captor Capital
$0.17
+4.9%
$0.17
$0.08
$0.31
N/AN/AN/A5,900 shs
PURE Bioscience, Inc. stock logo
PURE
PURE Bioscience
$0.07
-12.5%
$0.09
$0.06
$0.17
$7.83M0.1722,675 shs1,450 shs
13 Stocks Institutional Investors Won't Stop Buying Cover

Which stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Artemis Therapeutics Inc. stock logo
ATMS
Artemis Therapeutics
0.00%0.00%-20.00%-55.56%-86.62%
Cosmos Health Inc. stock logo
COSM
Cosmos Health
+0.64%+5.05%-2.16%-36.74%-78.75%
Captor Capital Corp. stock logo
CPTRF
Captor Capital
0.00%0.00%0.00%0.00%0.00%
PURE Bioscience, Inc. stock logo
PURE
PURE Bioscience
-11.39%-1.41%-12.50%-22.63%-50.00%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Artemis Therapeutics Inc. stock logo
ATMS
Artemis Therapeutics
N/AN/AN/AN/AN/AN/AN/AN/A
Cosmos Health Inc. stock logo
COSM
Cosmos Health
1.298 of 5 stars
0.05.00.00.02.32.50.6
Captor Capital Corp. stock logo
CPTRF
Captor Capital
N/AN/AN/AN/AN/AN/AN/AN/A
PURE Bioscience, Inc. stock logo
PURE
PURE Bioscience
N/AN/AN/AN/AN/AN/AN/AN/A

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Artemis Therapeutics Inc. stock logo
ATMS
Artemis Therapeutics
N/AN/AN/AN/A
Cosmos Health Inc. stock logo
COSM
Cosmos Health
3.00
BuyN/AN/A
Captor Capital Corp. stock logo
CPTRF
Captor Capital
N/AN/AN/AN/A
PURE Bioscience, Inc. stock logo
PURE
PURE Bioscience
N/AN/AN/AN/A

Current Analyst Ratings

Latest PURE, ATMS, COSM, and CPTRF Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
2/20/2024
Cosmos Health Inc. stock logo
COSM
Cosmos Health
Taglich Brothers
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingSpeculative Buy
(Data available from 5/4/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Artemis Therapeutics Inc. stock logo
ATMS
Artemis Therapeutics
$310K14.46N/AN/A($0.01) per share-4.00
Cosmos Health Inc. stock logo
COSM
Cosmos Health
$49.59M0.23N/AN/A$3.71 per share0.18
Captor Capital Corp. stock logo
CPTRF
Captor Capital
$31.65M0.28N/AN/A$0.30 per share0.58
PURE Bioscience, Inc. stock logo
PURE
PURE Bioscience
$1.87M4.19N/AN/AN/A

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Artemis Therapeutics Inc. stock logo
ATMS
Artemis Therapeutics
-$1.36MN/A0.00N/A-299.54%N/A-425.51%N/A
Cosmos Health Inc. stock logo
COSM
Cosmos Health
-$13.83MN/A0.00N/A-31.48%-28.54%-17.69%5/21/2024 (Estimated)
Captor Capital Corp. stock logo
CPTRF
Captor Capital
-$9.82M-$0.27N/AN/A-50.42%-92.97%-43.15%N/A
PURE Bioscience, Inc. stock logo
PURE
PURE Bioscience
-$3.96M-$0.06N/AN/A-194.80%-717.03%-326.30%6/12/2024 (Estimated)

Latest PURE, ATMS, COSM, and CPTRF Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
3/18/2024Q2 2024
PURE Bioscience, Inc. stock logo
PURE
PURE Bioscience
N/A-$0.01-$0.01-$0.01N/A$0.33 million
2/29/2024Q3 2024
Captor Capital Corp. stock logo
CPTRF
Captor Capital
N/A-$0.01-$0.01-$0.01N/A$6.88 million

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Artemis Therapeutics Inc. stock logo
ATMS
Artemis Therapeutics
N/AN/AN/AN/AN/A
Cosmos Health Inc. stock logo
COSM
Cosmos Health
N/AN/AN/AN/AN/A
Captor Capital Corp. stock logo
CPTRF
Captor Capital
N/AN/AN/AN/AN/A
PURE Bioscience, Inc. stock logo
PURE
PURE Bioscience
N/AN/AN/AN/AN/A

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Artemis Therapeutics Inc. stock logo
ATMS
Artemis Therapeutics
N/A
0.15
0.12
Cosmos Health Inc. stock logo
COSM
Cosmos Health
0.08
2.06
1.79
Captor Capital Corp. stock logo
CPTRF
Captor Capital
N/A
1.55
1.47
PURE Bioscience, Inc. stock logo
PURE
PURE Bioscience
N/A
1.72
1.59

Ownership

Institutional Ownership

CompanyInstitutional Ownership
Artemis Therapeutics Inc. stock logo
ATMS
Artemis Therapeutics
N/A
Cosmos Health Inc. stock logo
COSM
Cosmos Health
12.61%
Captor Capital Corp. stock logo
CPTRF
Captor Capital
N/A
PURE Bioscience, Inc. stock logo
PURE
PURE Bioscience
N/A

Insider Ownership

CompanyInsider Ownership
Artemis Therapeutics Inc. stock logo
ATMS
Artemis Therapeutics
7.45%
Cosmos Health Inc. stock logo
COSM
Cosmos Health
18.74%
Captor Capital Corp. stock logo
CPTRF
Captor Capital
N/A
PURE Bioscience, Inc. stock logo
PURE
PURE Bioscience
41.76%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Artemis Therapeutics Inc. stock logo
ATMS
Artemis Therapeutics
1112.03 million103.69 millionNot Optionable
Cosmos Health Inc. stock logo
COSM
Cosmos Health
10216.93 million13.76 millionOptionable
Captor Capital Corp. stock logo
CPTRF
Captor Capital
N/A52.10 millionN/ANot Optionable
PURE Bioscience, Inc. stock logo
PURE
PURE Bioscience
11111.86 million65.15 millionNot Optionable

PURE, ATMS, COSM, and CPTRF Headlines

SourceHeadline
EXCLUSIVE: Former Sprint CEO Dan Hesse On Going From Cleaning Sewers To Leading Billion-Dollar Tech CompaniesEXCLUSIVE: Former Sprint CEO Dan Hesse On Going From Cleaning Sewers To Leading Billion-Dollar Tech Companies
msn.com - May 2 at 8:17 PM
Neutral SONA BLW Precision Forging; target of Rs 630: Motilal OswalNeutral SONA BLW Precision Forging; target of Rs 630: Motilal Oswal
moneycontrol.com - May 2 at 9:39 AM
Vedanta Biosciences to Present at Upcoming Investor ConferencesVedanta Biosciences to Present at Upcoming Investor Conferences
finance.yahoo.com - April 29 at 10:03 AM
A scientist’s guide to tapping the in-shower body lotion trendA scientist’s guide to tapping the in-shower body lotion trend
cosmeticsbusiness.com - April 26 at 3:17 AM
East Butler, Shelby-Rising City track in action at Twin RiverEast Butler, Shelby-Rising City track in action at Twin River
columbustelegram.com - April 23 at 8:08 AM
Final Fantasy XVI The Rising Tide Review (PS5)Final Fantasy XVI The Rising Tide Review (PS5)
heypoorplayer.com - April 23 at 8:08 AM
Catalase Market Expansion: A Close Look at the US$ 516.6 Million Forecast by 2032 | Future Market Insights Inc.Catalase Market Expansion: A Close Look at the US$ 516.6 Million Forecast by 2032 | Future Market Insights Inc.
fmiblog.com - April 23 at 8:08 AM
PURE Bioscience, Inc. (PURE)PURE Bioscience, Inc. (PURE)
finance.yahoo.com - April 15 at 9:22 PM
Seragon Biosciencess RESTORIN Revolutionizes the Anti-Aging MarketSeragon Biosciences's RESTORIN Revolutionizes the Anti-Aging Market
ibtimes.com - April 15 at 4:22 PM
4JO: Burg Presents USAC Sprint Midwest Opener on Saturday4JO: Burg Presents USAC Sprint Midwest Opener on Saturday
speedwaydigest.com - April 13 at 8:30 PM
Pro-Palestine group at Harvard organizes student referendum on Israel divestmentPro-Palestine group at Harvard organizes student referendum on Israel divestment
forward.com - April 12 at 8:29 AM
Harvard Student Government Approves PSC Petition for Referendum on Israel DivestmentHarvard Student Government Approves PSC Petition for Referendum on Israel Divestment
thecrimson.com - April 11 at 10:20 AM
Top Iconic Brands to watch in 2024Top Iconic Brands to watch in 2024
timesofindia.indiatimes.com - April 1 at 12:36 PM
New school-wide dress code inspires unprecedented backlashNew school-wide dress code inspires unprecedented backlash
msuexponent.com - March 28 at 8:09 PM
UVA Law Professor Discusses Judicial Deference at Harvard Law School’s Annual Scalia LectureUVA Law Professor Discusses Judicial Deference at Harvard Law School’s Annual Scalia Lecture
thecrimson.com - March 28 at 1:25 PM
Scientists say theyre closer to reviving Mammoths. What could go wrong?Scientists say they're closer to reviving Mammoths. What could go wrong?
msn.com - March 28 at 1:25 PM
Sam Altmans mission to increase human lifespan with a $180 million shipping container experiment at Retro BiosciencesSam Altman's mission to increase human lifespan with a $180 million shipping container experiment at Retro Biosciences
msn.com - March 23 at 10:16 AM
PURE Bioscience Reports Fiscal Second Quarter 2024 Financial ResultsPURE Bioscience Reports Fiscal Second Quarter 2024 Financial Results
businesswire.com - March 18 at 4:05 PM
Research: Red clover can act to deliver improved silage qualityResearch: Red clover can act to deliver improved silage quality
agriland.ie - March 16 at 10:49 PM
As European dynamism gathers momentum, Elaia and partners double down with new deep tech fundAs European dynamism gathers momentum, Elaia and partners double down with new deep tech fund
yahoo.com - March 14 at 1:57 AM
Sophie Bai Creates Scientific Breakthroughs for Her Skincare Brand, PaviseSophie Bai Creates Scientific Breakthroughs for Her Skincare Brand, Pavise
wmagazine.com - March 13 at 8:06 PM
Kuros Biosciences AG: Kuros Reports 163% Growth in Direct MagnetOs Sales and 153% Increase in Total Medical Device Sales for the Full Year 2023Kuros Biosciences AG: Kuros Reports 163% Growth in Direct MagnetOs Sales and 153% Increase in Total Medical Device Sales for the Full Year 2023
finanznachrichten.de - March 13 at 10:05 AM
Kuros reports 163% growth in direct MagnetOs sales and 153% increase in total medical device sales for the full year 2023Kuros reports 163% growth in direct MagnetOs sales and 153% increase in total medical device sales for the full year 2023
markets.businessinsider.com - March 13 at 10:05 AM
Resurrecting the mammoth: Elephant breakthrough gets us a step closerResurrecting the mammoth: Elephant breakthrough gets us a step closer
newatlas.com - March 13 at 10:05 AM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Company Descriptions

Artemis Therapeutics logo

Artemis Therapeutics

OTCMKTS:ATMS
Artemis Therapeutics, Inc. is a biopharmaceutical company. It develops new treatments for serious and life-threatening infections. It Includes cytomegalovirus and malaria. The company was founded on April 22, 1997 and was headquartered in New York, NY.
Cosmos Health logo

Cosmos Health

NASDAQ:COSM
Cosmos Health Inc. provides proprietary line of branded and generic pharmaceuticals, nutraceuticals, over-the-counter medications, cosmetics, nursery, health care and baby products, and medical devices. Its nutraceutical product portfolio includes Sky Premium Life and Mediterranation. The company serves wholesale pharmaceutical distributors and independent retail pharmacies. It operates in Greece, Germany, the United Kingdom, Italy, Denmark, Croatia, and Cyprus. Cosmos Health Inc. was incorporated in 2009 and is headquartered in Chicago, Illinois.
Captor Capital logo

Captor Capital

OTCMKTS:CPTRF
Captor Capital Corp. engages in the manufacture and retail sale of cannabis products in the United States. It operates two dispensaries under the CHAI Cannabis Co. brand in Santa Cruz and Monterey, California, as well as operates an e-commerce site under the CHAI-brand. The company was formerly known as NWT Uranium Corp. and changed its name to Captor Capital Corp. in June 2017. Captor Capital Corp. was incorporated in 2003 and is based in Toronto, Canada.
PURE Bioscience logo

PURE Bioscience

OTCMKTS:PURE
PURE Bioscience, Inc. develops and commercializes antimicrobial products that provide solutions to the health and environmental challenges of pathogen and hygienic control in the United States and internationally. The company manufactures and distributes silver dihydrogen citrate (SDC), a non-toxic antimicrobial agent, which offers residual protection, as well as formulates with other compounds. It offers SDC-based disinfecting and sanitizing products, including PURE Hard Surface, a food contact surface sanitizer and disinfectant; PURE Control, a food contact processing aid for fresh produce and raw poultry; PURE Multi-Purpose and Floor Cleaner Concentrate to clean various resilient surfaces, including floors, glass, and food contact surfaces; and PURE Multi-Purpose Hi-Foam Cleaner Concentrate to clean stainless steel equipment, resilient floors, walls, and painted surfaces. The company also provides Axen30, a hard surface disinfectant; Axenohl, an antimicrobial formulation for use as a raw material ingredient in the manufacturing of consumer and commercial disinfecting and sanitizing products; and SILVÉRION, an antimicrobial formulation that is used against bacteria, viruses, yeasts, and molds. PURE Bioscience, Inc. was incorporated in 1992 and is headquartered in Rancho Cucamonga, California.